🔥Telegram İfşa

3/4 A distinct population of IL-1B+TNF+ myeloid cells are enriched in myocarditis samples.

4/4 IL-1B+TNF+ myeloid cells are associated with poorer clinical outcomes. These results nominate new targets for investigation into rational treatments to overcome these high mortality toxicities.

1/4 Published in Cancer Immunology Research! Evaluation of cardiac & skeletal muscle biopsies in patients w/myocarditis & myositis identified immune mechanisms possibly contributing to these fatal irAEs. MD Anderson Cancer Center @PamSharmaMDPhD Sumit Subudhi Nicolas Palaskas, MD Linghua Wang, MD, PhD aacrjournals.org/cancerimmunolr…

🧵 👇 💫

Congratulations to @JimAllisonPhD, PICI Center Director at MD Anderson, on his induction into the Inventors HOF. Dr. Allison invented immune checkpoint blockade therapy, a pivotal #immunotherapy advancement, and we are honored to work with him at PICI. invent.org/blog/inventors…

Driven by a passion for tumor immunology, Dr. Kenneth Hu started a research lab at MD Anderson dedicated to developing innovative tools for studying tumor cell interactions. Read about his work here: brnw.ch/21wK4MT #Immunology #EndCancer

Urothelial carcinoma: 8 insights about this common bladder cancer | MD Anderson Cancer Center mdanderson.org/cancerwise/uro…

Thank you to Conquer Cancer, the ASCO Foundation for supporting our work MD Anderson Cancer Center with a Career Development Award! Chris Logothetis, Daniel E. Frigo, Ph.D., and I will be exploring the overlap syndrome hypothesis focusing on AR signaling, patient metabolism, and outcomes with ARSI

⚡️JOIN US at #ASCO24: MD Anderson Cancer Center Genitourinary (GU) Oncology Dep't Honored & grateful to work in a powerhouse group with incredible mentors Omar Alhalabi, MD Matt Campbell MD, MS & ironclad support from stellar faculty #GUStrong #GUSM 👉Full MDA Program: mdanderson.org/documents/rese…

ASPirE gathered so many incredible clinicians, researchers and change makers at #ASCO24 - humbling and inspiring how much this group is devoted to improving immunotherapy outcomes 💪 #irAE

Dr. Tannir continuing his legacy by supporting young investigators with “Nizar Tannir Endowed Merit Award”. Let’s give him a standing ovation #NizarTannir MD Anderson Cancer Center

⚡️NOW IN PRESS: Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy🧬 #PrecisionOncology 👉GU ASCO #GU24: Original multi-institutional series on off-label use of lurbi in SCBC-enriched GU cohorts Omar Alhalabi, MD

India-United States Cancer Moonshot Dialogue. Forging collaborations to tackle cancer together. With @PamSharmaMDPhD @JimAllisonPhD #globalmoonshot #USIndiacancerdialogue ⁦Dr. Catharine Young⁩ MD Anderson Cancer Center⁩

Dr. Bilal Siddiqui says he's optimistic about adding T cell redirectors to form "part of the treatment arsenal" for prostate cancer. Bilal A. Siddiqui, MD #EndCancer

Poetry challenge at #PCFRetreat24 Our haiku about science and scientific challenges. Must rise to the occasion! 💪🏽 Prostate Cancer Foundation PCF Science

In nature, a collaboration with Kerry Reynolds, Alexandra-Chloé Villani Lab, Steve Blum, Daniel Zlotoff from Mass General Cancer Center, MassGeneral Medicine and others. Immune response in checkpoint myocarditis. Sincere thanks to the patients and families. MGH Cardiovascular Research Center International Cardio-Oncology Society. Mass General Heart nature.com/articles/s4158…

From bold resolutions, to big breakthroughs, CRI scientists including CRI Tech Impact Award Grantee Dr. Rik G.H. Lindeboom The Netherlands Cancer Institute are aiming to advance cancer research in many ways throughout 2025. Discover more New Year's resolutions in our newest blog: bit.ly/42ddE9V

Had the opportunity to contribute my thoughts on President Biden’s recent prostate diagnosis— check it out:

Thank you Sara Sidner and CNN for having me. Our thoughts are with Joe Biden and his family as they navigate this tough diagnosis and determine a treatment plan that best fits the former President’s needs. #biden #prostatecancer #cnn #BreakingNews

Are medical experts surprised at former President Biden’s late diagnosis? Here’s what could have happened— Sara Sidner CNN CNN Breaking News MD Anderson Cancer Center